Medical Device News Magazine

Red One Medical and Prytime Medical Devices Announce Exclusive Partnership

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Red One Medical, a proven government contractor providing best-in-class medical supplies to Veterans Affairs and the Department of Defense, is proud to exclusively partner with Prytime Medical Devices, Inc. (The REBOA Company™), a privately held medical technology company focused on minimally invasive solutions for trauma.

As a Service Disabled Veteran Owned Small Business (SDVOSB), Red One Medical specializes in serving the US military’s needs in Operational Medicine, Military Treatment Facilities and the VA.

Prytime Medical’s newly refined flagship product, the ER-REBOA™ PLUS Catheter, provides clinicians  an effective tool to control bleeding and stabilize patients in hemorrhagic shock, utilizing a minimally invasive technique called REBOA (Resuscitative Endovascular Balloon Occlusion of the Aorta). The catheter was designed specifically for emergency and critical care environments, making it a perfect match for combat medicine.

“Our flagship technology and technique arose from military medicine in the field, and now we’re bringing the lessons learned from war to civilian trauma back home,” said Prytime Medical’s CEO David Spencer. “Our partnership with veteran-owned Red One Medical supports our original mission to support combat wounded military members and those who treat them.”

“We’re proud to get these cutting-edge medical devices into the hands of US military trauma surgeons and other medical providers close to the point of injury,” said Red One Medical’s CEO Charles Pollak. “Red One works hard to bridge the gap between private sector innovations and government contracting, because we know these devices can save lives.”

The new PLUS design improves on the original ER-REBOA™ by adding five new features to help control massive non-compressible hemorrhage, including:
1) “Landing zone” markers to easily identify zones 1 and 3
2) Repackaged peel away sheath  to reduce prep time
3) Length markers on both sides of catheter for better visibility
4) Documentation tag to capture critical information
5) Guidewire compatible  for subsequent vascular procedures

Prytime Medical also offers the ER-REBOA™ PLUS Training Catheter and ARTI Simulator for arterial access training.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”